Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | CA3 | P07451 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | CA4 | P22748 | 1/20 | 0.55 |
| ▸ | CA6 | P23280 | 1/20 | 0.55 |
| ▸ | CA5A | P35218 | 1/20 | 0.55 |
| ▸ | CA7 | P43166 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.55 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31208074 | 1.00 | CA12 (0.55) | CA12CA1CA2CA3PKM | |
| SCHEMBL31355236 | 0.88 | SMN1; SMN2 (0.52) | CA12CA1CA2CA3PKM | |
| SCHEMBL5838887 | 0.85 | CYP3A4 (0.58) | CA12CA1CA2CA3PKM | |
| SCHEMBL6465454 | 0.83 | CYP3A4 (0.47) | CA12CA1CA2CA3PKM | |
| SCHEMBL15513877 | 0.82 | PKM (0.57) | CA12CA1CA2CA3PKM | |
| SCHEMBL18341497 | 0.82 | NPC1 (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL4847814 | 0.81 | KDM4E (0.53) | PKMKDM4EALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL1651653 | 0.81 | KDM4E (0.49) | KDM4EALDH1A1SMN1; SMN2MAPTUSP2 | |
| SCHEMBL6507929 | 0.81 | SMN1; SMN2 (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL7824527 | 0.81 | CA12 (0.78) | CA12CA1CA2CA3PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250214921-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | KAO CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| US-20250214920-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | KAO CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| EP-4501897-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | Kao Corporation (JP) | 2025-02-05 | — | — | EP | disclosed |
| EP-4501896-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | Kao Corporation (JP) | 2025-02-05 | — | — | EP | disclosed |
| WO-2023189723-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | 花王株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023189722-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | 花王株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2019078645-A1 | PHARMACEUTICAL COMPOSITION FOR ANTICANCER TREATMENT AND PREPARATION METHOD THEREFOR | 충남대학교 산학협력단 | 2019-04-25 | — | — | WO | disclosed |
| EP-1871844-B1 | BUBBLE COMPOSITION WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2014-08-27 | — | — | EP | disclosed |
| WO-2010042600-A2 | PHOTO-ACTIVATABLE THERAPEUTIC AGENTS AND METHODS OF USING | THE UAB RESEARCH FOUNDATION (US) | 2010-04-15 | — | — | WO | disclosed |
| EP-1871844-A2 | NOVELTY COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C Technologies LLC (US) | 2008-01-02 | — | — | EP | disclosed |
| US-20070010400-A1 | Use of color changing indicators in consumer products | C2C TECHNOLOGIES, LLC | 2007-01-11 | — | — | US | disclosed |
| US-20060257439-A1 | Cleansing compositions with color changing indicator | CRAYOLA LLC | 2006-11-16 | — | — | US | disclosed |
| US-20060236470-A1 | Novelty compositions with color changing indicator | CRAYOLA LLC | 2006-10-26 | — | — | US | disclosed |
| WO-2006105193-A2 | PERSONAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006105260-A1 | ORAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006105261-A1 | CLEANSING COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006105191-A2 | NOVELTY COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| US-20060222675-A1 | Personal care compositions with color changing indicator | C2C TECHNOLOGIES, LLC | 2006-10-05 | — | — | US | disclosed |
| US-20060222601-A1 | Oral care compositions with color changing indicator | C2C TECHNOLOGIES, LLC | 2006-10-05 | — | — | US | disclosed |
| CN-85107017-A | Preparation three ring pyridazinones dihydro compounds and the method that contains the pharmaceutical composition of this compound | — | 1987-04-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214920-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | CYP4F2, DUOX1, BCKDK | CA12 1156/4885CA1 1048/4885CA2 2198/4885 |
| US-20060222675-A1 | Personal care compositions with color changing indicator | CUTA, POLR1C, TYR | CA12 2044/4885CA1 1814/4885CA2 253/4885 |
| US-20060257439-A1 | Cleansing compositions with color changing indicator | WASHC5, WASHC4, FHIT | CA12 15/4885CA1 139/4885CA2 30/4885 |
| US-20250214921-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | HSD17B7, HSD17B12, BCKDK | CA12 2616/4885CA1 2942/4885CA2 3272/4885 |
| US-20060222601-A1 | Oral care compositions with color changing indicator | CA9, CA7, TAS2R7 | CA12 38/4885CA1 70/4885CA2 29/4885 |
| US-20070010400-A1 | Use of color changing indicators in consumer products | NQO2, CA4, CA7 | CA12 16/4885CA1 208/4885CA2 7/4885 |
| US-20060236470-A1 | Novelty compositions with color changing indicator | MITF, CRABP2, SHH | CA12 997/4885CA1 1914/4885CA2 2888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.